miR-223 appears to participate in the TLR signaling pathway, leading to the reduced transcription and secretion of IL-1, IL-6, and IL-8, while activating innate immunity during mastitis pathogenesis, thereby mitigating inflammation [42,45]. Here, IL6 is linked to mastitis.